Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients

New England Journal of Medicine

Volumn 339, Issue 19, 1998, Pages 1358-3663

  Regamey, Nicolas ^a   Tamm, Michael ^b   Wernli, Marion ^a   Witschi, Anne ^a   Thiel, Gilbert ^b   Cathomas, Gieri ^c   Erb, Peter ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN M ANTIBODY; OKT 3; PREDNISONE; RECOMBINANT HUMAN HERPESVIRUS 8 PROTEIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT INFECTION; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; INFECTION RISK; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEROPREVALENCE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; FEMALE; FOLLOW-UP STUDIES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; TISSUE DONORS;

EID: 0032487835     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199811053391903     Document Type: Article

References (24)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
2. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995;332:1181-5.
3. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995;1:707-8.
4. Cathomas G, McGandy CE, Terracciano LM, Itin PH, De Rosa G, Gudat F. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. J Clin Pathol 1996; 49:631-3.
5. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10:175-80.
6. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998;90:395-7.
7. Gao S-J, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335:233-41.
8. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991;23:1101-3.
9. Farge D. Kaposi's sarcoma in organ transplant recipients: the Collaborative Transplantation Research Group of Ile de France. Eur J Med 1993; 2:339-43.
10. al-Sulaiman MH, al-Khader AA. Kaposi's sarcoma in renal transplant recipients. Transplant Sci 1994;4:46-60.
11. Qunibi W, Akhtar M, Sheth K, et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84:225-32.
12. Shmueli D, Shapira Z, Yussim A, Nakache R, Ram Z, Shaharabani E. The incidence of Kaposi sarcoma in renal transplant patients and its relation to immunosuppression. Transplant Proc 1989;21:3209-10.
13. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60:1485-91.
14. Cathomas G, Tamm M, McGandy CE, et al. Transplantation-associated malignancies: restriction of human herpes virus 8 to Kaposi's sarcoma. Transplantation 1997;64:175-8.
15. Penn I. Cancers in cyclosporine treated vs azathioprine-treated patients. Transplant Proc 1996;28:876-8.
16. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-24. [Erratum, Nat Med 1996; 2:1041.]
17. Blackbourn DJ, Levy JA. Human herpesvirus 8 in semen and prostate. AIDS 1997;11:249-50.
18. Regamey N, Cathomas G, Schwager M, Wernli M, Harr T, Erb P. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol 1998;36:1784-6.
19. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998;338:948-54.
20. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-8.
21. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2:925-8.
22. Lin SF, Sun R, Heston L, et al. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 1997;71:3069-76.
23. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
24. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997;90:2826-9.